1. Sato T, Fujieda M, Tanaka E, Miyamura M, Chikamoto H, Hisano M, et al. Monitoring of Epstein-Barr virus load and antibody in pediatric renal transplant patients. Pediatr Int. 2008 Aug;50(4):454.
2. Lin D, Lavender H, Soilleux EJ, O’Callaghan CA. NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem. 2012 Feb;287(6):4299.
3. Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol. 2007 May;68(5):362–7.
4. Zou Y, Stastny P, Süsal C, Döhler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med. 2007 Sep;357(13):1293–300.
5. Carter V, Shenton BK, Jaques B, Turner D, Talbot D, Gupta A, et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc. 2005 Mar;37(2):654.